Harvard Infectious Diseases In Adults 2026

• Target Audience: infectious disease physicians, internists, hospital medicine physicians, family practice physicians, pulmonologists, critical care medicine physicians, emergency medicine physicians
• Sample video: contact me for sample video
• Information:

1. Overview

Infectious Diseases in Adults 2026 provides state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging.

State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases in Adults

This comprehensive CME program, now in its 50th year, ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:

Optimal decision-making across a range of common and unusual infectious diseases

Newer antimicrobials and treatment strategies for highly resistant infections

Prevention and treatment of infections in immunocompromised hosts

Update on antifungal diagnostics and therapy

State-of-the-art and multidisciplinary approaches to common infections

Clinical approaches to complex, rare, and “don’t-miss” infections

New, evolving, emerging, and re-emerging infectious diseases

Infections in persons with substance use disorder

What’s new in HIV prevention and management

The latest on COVID-19, including long COVID

Adult vaccinations in 2026

In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)

Highlights of the 2026 Program

Expanded Case-Based and Problem-Solving Education

The 2026 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops.

Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care.

Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, resistant Gram-positive and Gram-negative infections, management of endocarditis and cardiac device infections, musculoskeletal infections, and nontuberculous mycobacterial infections.

Treating Highly Resistant Infections, including:

MRSA and VISA (vancomycin-intermediate Staph aureus)

Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods

Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms

Vancomycin-resistant enterococci (VRE)

Resistant fungal infections, including Aspergillus, other molds, and resistant Candidal infections

Nontuberculous mycobacteria (NTM)

Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment, including:

Respiratory viral infections, including COVID-19

New and updated vaccine guidance

Infections in the expanding populations of immunocompromised hosts

Infections in persons with substance use disorder

Infections of travelers and foreign-born persons

Systemic fungal infections

Native and device-related orthopedic infections

Central nervous system (CNS) infections

Native and prosthetic valve endocarditis, and cardiac device infections

Ear, nose, and throat (ENT) and eye infections

Skin and soft tissue infections

Bronchiectasis and pneumonia

HIV and its infectious and noninfectious complications

PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection

Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs

Hepatitis B and C infections

Tick- and mosquito-borne infections

Clostridioides difficile infection, the gut microbiome, and pre- and probiotics

Complicated urinary tract infections

Intra-abdominal infections

Challenging, Rare, and Emerging Infectious Diseases, including:

Highly pathogenic avian flu

Re-emergence of vaccine-preventable diseases, including poliomyelitis

Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus

Global infectious diseases of clinical importance

Clinical Decision-Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

Selecting the best antimicrobial and duration of treatment

Rapid detection and empiric treatment of life-threatening infectious diseases

Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials

Optimizing empiric antimicrobial therapy: what to start, and how and when to de-escalate

Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:

Antimicrobial stewardship to prevent resistance and reduce cost

Early inpatient ID consultations to improve outcomes

Strategies for management of infection in persons who inject drugs (PWID)

New in 2026: Advanced Learning Modules

HIV

Mycobacterial Infections

Each of these expanded learning modules provides advanced content for learners seeking to build additional expertise in these two important areas. These modules offer on-demand, self-paced lectures as well as live Meet-the-Professors sessions, where our expert faculty discuss cases submitted by our course participants.

2. Learning Objectives

Utilize the latest strategies for the prevention, diagnosis, and management of important infectious disease syndromes in immunocompetent and immunocompromised patients

Describe updated guidelines on the treatment of infectious diseases

Summarize principles of judicious antimicrobial selection, dose, route, and duration to optimize patient outcomes while preventing resistance and lowering cost

Describe evidence-based treatments as well as new treatment paradigms for resistant organisms and difficult-to-treat infections

Recognize the role of novel, rapid diagnostics of infection and resistance in infectious disease practice

Recognize the epidemiologic risk factors for emerging infectious diseases and provide optimal empiric and target therapies for infections

Design and implement multidisciplinary care for patients in areas such as hematology oncology, solid organ transplantation, musculoskeletal infections, endocarditis, abdominal infections, and genitourinary infections

3. Target Audience

Best for infectious disease physicians and internists who want updates on antimicrobial stewardship, HIV, and managing complex infections.

Who Should Participate

Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:

Infectious Diseases

Hospital Medicine

Internal Medicine

Family Practice

Pulmonary and Critical Care Medicine

Emergency Medicine

…and others who care for patients with infectious diseases

4. Topics

01 Advancing Patient Care Through Antimicrobial Stewardship

02 Update on Antifungal Diagnostics and Therapy

03 Plenary The Future of Global Public Health Lessons from HIV

04 Live Q&A Dr. Linda-Gail Bekker

05 Eye and ENT Infections What You Need to Know in 2026

06 Live Q&A Drs. Miriam Barshak, Nesli Basgoz, Alyssa Letourneau, and Michael Mansour

07 Multidisciplinary Panel Workshop 1 Resistant Gram-Positive Infections

08 Multidisciplinary Panel Workshop 2 Resistant Gram-Negative Infections

09 Live Q&A Drs. Alyssa Letourneau, Roby Bhattacharyya, Cecilia Li, and Tiffany Wu

10 C. difficile Update, the Gut Microbiome, and Pre- and Probiotics

11 Skin and Soft Tissue Infections Current Best Practices for Clinicians

12 Live Q&A Drs. Sandra Nelson and Elizabeth Hohmann

13 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy

14 Infections in Hematologic Malignancies and Stem Cell Transplantation

15 Flummoxing Cases in Fungal Infections

16 Live Q&A Drs. Camille Kotton, Michael Mansour, Sarah Hammond, and Sarah Turbett

17 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections

19 Navigating New Vaccines Updates and Recommendations

20 Pre- and Post-Exposure Prophylaxis for HIV and STIs

21 What’s New in the Care of People with HIV in 2026

22 Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections

23 Live Q&A Drs. Rajesh Gandhi, Nesli Basgoz, Kevin Ard, and Camille Kotton

24 Self-Paced Study HIV Perinatal HIV Infection

25 Self-Paced Study HIV Perinatal Metabolic Complications of HIV

26 Self-Paced Study HIV Perinatal CROI Updates

27 Self-Paced Study HIV Perinatal HIV Resistance

28 Introduction to TB, Latent TB Infection, and Drug-Susceptible TB

29 Drug-Resistant TB and TB in Special Populations

30 Live Q&A Drs. Rocio Hurtado and Jodian Pinkney

31 Bronchiectasis and NTM Infections Anatomic and Clinical Approaches

32 The Latest on Major Respiratory Viral Infections

33 Innovations in HBV and HCV Care Updates for 2026

34 Live Q&A Drs. Nesli Basgoz, Arthur Kim, and Michael Ison

35 Live New England Journal of Medicine Clinicopathologic Conference (CPC) Please note This event will not be recorded

37 Global Infectious Diseases Case-Based Updates

38 Live Q&A Dr. Edward T. Ryan

39 Multidisciplinary Panel Workshop 3 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Pulmonary

40 Multidisciplinary Panel Workshop 4 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Extrapulmonary

41 Live Q&A Drs. Rocio Hurtado, Michael Lanuti, Christopher Richards, Kristen Hysell, Alex Rock, and Alyssa Letourneau

42 Encephalitis and Meningitis Guidelines and Best Practices

43 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, and Rickettsia

44 Live Q&A Drs. Allan Tunkel and Kimon Zachary

45 Bone and Joint infections A Conceptual Framework

46 Staphylococcus aureus Déjà Vu All Over Again

47 Live Q&A Drs. Sandra Nelson and Henry Chambers

48 Multidisciplinary Panel Workshop 5 Native Bone Infections

49 Multidisciplinary Panel Workshop 6 Orthopedic Device Infections Prosthetic Joint Infections

50 Live Q&A Drs. Sandra Nelson, Hayden Box, F. Joseph Simeone, and Jeremy Goverman VIDEO NOT RELEASE

51 New and Emerging Viruses Clinical Insights for Frontline Providers and ID Specialists

52 KEYNOTE Polio The Unfinished Story

53 Live Q&A Drs. Martin Hirsch and David Oshinsky VIDEO NOT RELEASE

54 Intra-abdominal Infections A Conceptual Framework

55 Urinary Tract Infections A Conceptual Framework

56 Critical Care ID and Sepsis for the ID Clinician

57 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, and Lisa Bebell VIDEO NOT RELEASE

58 Multidisciplinary Workshop 7 Management of Complex Intra-abdominal Infections

59 Multidisciplinary Workshop 8 Management of Complex Urinary Tract Infections

60 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, Peter Fagenholz, Vincent Wu, Kristen Hung, and Lori Jones

61 Endocarditis and Cardiac Device Infections

62 The Syndemic of SUD and Infection Updated Approaches for 2026

63 Live Q&A Drs. Molly Paras and Jennifer Johnson

64 Multidisciplinary Workshop 9 Management of Endocarditis

65 Multidisciplinary Workshop 10 Management of Cardiac Device Infections

66 Live Q&A Drs. Molly Paras, Anne Duckles, Arminder Jassar, Shaan Khurshid, and Evin Yucel